Pharmaceutical company, Sanofi, will eliminate jobs in France and Germany and end new in-house cardiology research programmes.
The post Job cuts limit cardiovascular and diabetes research and development appeared first on European Pharmaceutical Review.
Original Article: Job cuts limit cardiovascular and diabetes research and development